103 related articles for article (PubMed ID: 8558776)
1. [Overexpressed p53 protein and cell-proliferative activity disappear or remarkably decrease in neoplastic CGA-positive endocrine and Paneth cells in cancer or dysplasia of ulcerative colitis].
Matsuda K; Watanabe H; Ohta T; Ajioka Y
Nihon Shokakibyo Gakkai Zasshi; 1995 Dec; 92(12):1922-8. PubMed ID: 8558776
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical analysis of chromogranin A and p53 expressions in ulcerative colitis-associated neoplasia: neuroendocrine differentiation as an early event in the colitis-neoplasia sequence.
Shigaki K; Mitomi H; Fujimori T; Ichikawa K; Tomita S; Imura J; Fujii S; Itabashi M; Kameoka S; Sahara R; Takenoshita S
Hum Pathol; 2013 Nov; 44(11):2393-9. PubMed ID: 24029705
[TBL] [Abstract][Full Text] [Related]
3. p53 immunohistochemistry of ulcerative colitis-associated with dysplasia and carcinoma.
Sato A; MacHinami R
Pathol Int; 1999 Oct; 49(10):858-68. PubMed ID: 10571818
[TBL] [Abstract][Full Text] [Related]
4. Enhanced epithelial cell turnover associated with p53 accumulation and high p21WAF1/CIP1 expression in ulcerative colitis.
Arai N; Mitomi H; Ohtani Y; Igarashi M; Kakita A; Okayasu I
Mod Pathol; 1999 Jun; 12(6):604-11. PubMed ID: 10392637
[TBL] [Abstract][Full Text] [Related]
5. Indefinite dysplasia in ulcerative colitis has little clinical significance and is not associated with p53 protein accumulation.
Papatheodoridis GV; Zizi-Serbetzoglou A; Xourgias V; Elemenoglou I; Karamanolis DG
Am J Gastroenterol; 1998 Feb; 93(2):285-6. PubMed ID: 9468272
[No Abstract] [Full Text] [Related]
6. Disruption of the p53-p53r2 DNA repair system in ulcerative colitis contributes to colon tumorigenesis.
Yoshida T; Haga S; Numata Y; Yamashita K; Mikami T; Ogawa T; Ohkusa T; Okayasu I
Int J Cancer; 2006 Mar; 118(6):1395-403. PubMed ID: 16206288
[TBL] [Abstract][Full Text] [Related]
7. p53 Expression as a Diagnostic Biomarker in Ulcerative Colitis-Associated Cancer.
Kobayashi K; Tomita H; Shimizu M; Tanaka T; Suzui N; Miyazaki T; Hara A
Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28621756
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical analysis of REG Iα expression in ulcerative colitis-associated neoplastic lesions.
Tanaka H; Fukui H; Fujii S; Sekikawa A; Yamagishi H; Ichikawa K; Tomita S; Imura J; Yasuda Y; Chiba T; Fujimori T
Digestion; 2011; 83(3):204-9. PubMed ID: 21266817
[TBL] [Abstract][Full Text] [Related]
9. Ulcerative colitis with overexpression of p53 preceding overt histological abnormalities of the epithelium.
Matsuda K; Watanabe H; Ajioka Y; Kobayashi M; Saito H; Sasaki M; Yasuda K; Kuwabara A; Nishikura K; Muto T
J Gastroenterol; 1996 Dec; 31(6):860-7. PubMed ID: 9027653
[TBL] [Abstract][Full Text] [Related]
10. Comparison of p53 immunoexpression with allelic loss of p53 in ulcerative colitis-associated dysplasia and carcinoma.
Fogt F; Zhuang Z; Poremba C; Dockhorn-Dworniczak B; Vortmeyer A
Oncol Rep; 1998; 5(2):477-80. PubMed ID: 9468583
[TBL] [Abstract][Full Text] [Related]
11. Fecal chromogranins and secretogranins are increased in patients with ulcerative colitis but are not associated with disease activity.
Strid H; Simrén M; Lasson A; Isaksson S; Stridsberg M; Öhman L
J Crohns Colitis; 2013 Dec; 7(12):e615-22. PubMed ID: 23694857
[TBL] [Abstract][Full Text] [Related]
12. Expression of ATF6 as a marker of pre-cancerous atypical change in ulcerative colitis-associated colorectal cancer: a potential role in the management of dysplasia.
Hanaoka M; Ishikawa T; Ishiguro M; Tokura M; Yamauchi S; Kikuchi A; Uetake H; Yasuno M; Kawano T
J Gastroenterol; 2018 May; 53(5):631-641. PubMed ID: 28884228
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological study of chromogranin A, B and BRCA1 expression in node-negative breast carcinoma.
Yoshida R; Ohuchi N; Kimura N
Oncol Rep; 2002; 9(6):1363-7. PubMed ID: 12375049
[TBL] [Abstract][Full Text] [Related]
14. Assessment of dysplasia, mucosal mucins, p53 protein expression, and DNA content in ulcerative colitis patients with colectomy and ileorectal anastomosis.
Navratil E; Stettler C; Paul G; Vilotte J; Vissuzaine C; Mignon M; Potet F
Scand J Gastroenterol; 1995 Apr; 30(4):361-6. PubMed ID: 7610353
[TBL] [Abstract][Full Text] [Related]
15. Role of immunohistochemical markers in predicting progression of dysplasia to advanced neoplasia in patients with ulcerative colitis.
van Schaik FD; Oldenburg B; Offerhaus GJ; Schipper ME; Vleggaar FP; Siersema PD; van Oijen MG; Ten Kate FJ
Inflamm Bowel Dis; 2012 Mar; 18(3):480-8. PubMed ID: 21509910
[TBL] [Abstract][Full Text] [Related]
16. Significant correlation of morphological remodeling in ulcerative colitis with disease duration and between elevated p53 and p21 expression in rectal mucosa and neoplastic development.
Mitsuhashi J; Mikami T; Saigenji K; Okayasu I
Pathol Int; 2005 Mar; 55(3):113-21. PubMed ID: 15743319
[TBL] [Abstract][Full Text] [Related]
17. Comparison of genetic alterations in colonic adenoma and ulcerative colitis-associated dysplasia and carcinoma.
Fogt F; Vortmeyer AO; Goldman H; Giordano TJ; Merino MJ; Zhuang Z
Hum Pathol; 1998 Feb; 29(2):131-6. PubMed ID: 9490271
[TBL] [Abstract][Full Text] [Related]
18. [Neuroendocrine changes in patients with inflammatory diseases and colonic cancer].
Rakhimova OIu; Paĭzullaeva ZK; Aleksandrov VB
Klin Med (Mosk); 2010; 88(4):56-60. PubMed ID: 20919572
[TBL] [Abstract][Full Text] [Related]
19. Usefulness of analysis of p53 alteration and observation of surface microstructure for diagnosis of ulcerative colitis-associated colorectal neoplasia.
Fujii S; Fujimori T; Chiba T
J Exp Clin Cancer Res; 2003 Mar; 22(1):107-15. PubMed ID: 12725330
[TBL] [Abstract][Full Text] [Related]
20. Increased expression of proliferative Ki-67 nuclear antigen is correlated with dysplastic colorectal epithelium in ulcerative colitis.
Sjöqvist U; Ost A; Löfberg R
Int J Colorectal Dis; 1999 Apr; 14(2):107-13. PubMed ID: 10367256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]